Stoyanova Lab
  • Home
  • Research
  • Our Group
  • Alumni
  • Publications
  • News
  • Join Our Team
  • Donate
    • Sponsors
  • Contact
Stoyanova Lab
  • Home
  • Research
  • Our Group
  • Alumni
  • Publications
  • News
  • Join Our Team
  • Donate
    • Sponsors
  • Contact

ACAA2 is a novel molecular indicator for cancers with neuroendocrine phenotype

October 5, 2023

Stoyanova lab is excited to share our study on identifying ACAA2 as a potential new molecular indicator for cancers with neuroendocrine phenotype. Congratulations!

Link to publication: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667239/

October 5, 2023

NewsUCLA

FacebookXPinterestRedditDeliciousWhatsappEmail
  • PreviousBhavya Panday joins Dr. Stoyanova’s lab as an undergranduate student from UCLA!

  • NextExciting News: Dr. Alifiani Bonita Hartono wins Second Place at the UCLA Molecular and Medical Pharmacology Departmental Retreat

Related Posts ...

Exciting News: Dr. Tanya Stoyanova receives 2025 Neuroendocrine Tumor Research Foundation Pilot Award

News, UCLA

Exciting News: Dr. Shiqin (Laura) Liu awarded grant from Department of Defense to develop immunotherapy for small-cell lung cancer

News, UCLA

Logo

ADDRESS

Los Angeles
CA 90095, USA
tstoyanova@mednet.ucla.edu

+1 (310) 825 0955

QUICK LINKS

  • UCLA
  • UCLA Health
  • Positions Available
© Stoyanova Lab. All Rights Reserved. | admin login